Antonio de la Cruz Miranda, MD
Sports Medicine · Bayamon, PRNPI 1972578284
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.5%), education and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Smith+Nephew at 42.7% of the total. Reporting peaked in 2019 at $5,188 and has fallen 97.1% since, to $149 in 2025.
Across 28 payments — averaging $281.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Arthrex$2K
- RMC Orthopedic & Surgical, Inc.$2K
- Merck$100
- Johnson & Johnson$100
- Ferring Pharmaceuticals Inc.$34
- plus $18 from 1 others
What the payments were for
- Travel & lodging$3,51445%
- Food & beverage$1,33917%
- Education$3,03638%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 10 | $3,366 |
| Arthrex | 7 | $2,230 |
| RMC Orthopedic & Surgical, Inc. | 6 | $2,041 |
| Merck | 1 | $100 |
| Johnson & Johnson | 1 | $100 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| PBG Puerto Rico LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,890 in reported general payments places this provider in the 75th percentile of 27 sports medicine providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Potassium | 2,002 | $57,287 |
| Diclofenac Sodium | 934 | $20,062 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 106 | $1,187 |
| Gabapentin | 245 | $1,107 |
| Cyclobenzaprine Hcl | 147 | $714 |
| Celecoxib | 41 | $676 |
| Cefadroxil | 94 | $465 |
| Mupirocin | 37 | $295 |
| Nabumetone | 16 | $233 |
| Zolpidem Tartrate | 52 | $231 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $74 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Bayamon
- Felipe Fontanez-SullivanBayamon$4K
- Antonio Soler SalasBayamon$770
- David Soto QuijanoBayamon$179
- Joseph Fernandez CabreraBayamon$13
- Pedro Tort SaadeGuaynabo$41K
- Lionel LazaroSan Juan$38K
- Magdiel Mayol UrdazCarolina$28K
- Omar Rodriguez AlejandroSan Juan$25K
- Artemio Torres MartinezManati$20K
- Jose Echenique AranaSan Juan$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.